Cargando…

Serum Amyloid A in lung transplantation

BACKGROUND: Serum Amyloid A (SAA) is an acute phase protein and we analyzed its concentrations in lung transplantated patients (LTX). METHODS: 26 LTX patients (58.6 ± 11 years) and 11 healthy controls (55 ± 11.3 years). Three groups of LTX patients: acute rejection (AR, 7) bronchiolitis obliterans s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vietri, Lucia, Bargagli, Elena, Bennett, David, Fossi, Antonella, Cameli, Paolo, Bergantini, Laura, d’Alessandro, Miriana, Paladini, Piero, Luzzi, Luca, Gentili, Francesco, Mazzei, Maria Antonietta, Spina, Donatella, Sestini, Piersante, Rottoli, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mattioli 1885 2020
Materias:	Original Article: Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569538/ https://www.ncbi.nlm.nih.gov/pubmed/33093763 http://dx.doi.org/10.36141/svdld.v37i1.8775

Ejemplares similares

The Role of Galectins in Chronic Lung Allograft Dysfunction
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena
por: Vietri, Lucia, et al.
Publicado: (2020)

Regulatory and Effector Cell Disequilibrium in Patients with Acute Cellular Rejection and Chronic Lung Allograft Dysfunction after Lung Transplantation: Comparison of Peripheral and Alveolar Distribution
por: Bergantini, Laura, et al.
Publicado: (2021)

Characterization of NKG2-A/-C, Kir and CD57 on NK Cells Stimulated with pp65 and IE-1 Antigens in Patients Awaiting Lung Transplant
por: Bergantini, Laura, et al.
Publicado: (2022)

Prognostic Biomarkers of Sarcoidosis: A Comparative Study of Serum Chitotriosidase, ACE, Lysozyme, and KL-6
por: Bergantini, Laura, et al.
Publicado: (2019)

Alveolar Nitric Oxide as a Biomarker of COVID-19 Lung Sequelae: A Pivotal Study
por: Cameli, Paolo, et al.
Publicado: (2021)

Utility of serological biomarker’ panels for diagnostic accuracy of interstitial lung diseases
por: Bergantini, Laura, et al.
Publicado: (2020)

The role of the combination of echo-HRCT score as a tool to evaluate the presence of pulmonary hypertension in idiopathic pulmonary fibrosis
por: Refini, Rosa Metella, et al.
Publicado: (2020)

Long-Term Follow-Up of Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone or Nintedanib: A Real-Life Comparison Study
por: Cameli, Paolo, et al.
Publicado: (2020)

Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review
por: Bergantini, Laura, et al.
Publicado: (2022)

Correction to: Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis
por: Bennett, David, et al.
Publicado: (2020)

Follicular T Helper and Breg Cell Balance in Severe Allergic Asthma Before and After Omalizumab Therapy
por: Bergantini, Laura, et al.
Publicado: (2021)

Cytomegalovirus Infection Is Associated with Development of Chronic Lung Allograft Dysfunction
por: Bennett, David, et al.
Publicado: (2022)

Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis
por: Bennett, David, et al.
Publicado: (2020)

NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19
por: Bergantini, Laura, et al.
Publicado: (2021)

Adaptive immune system in pulmonary sarcoidosis—Comparison of peripheral and alveolar biomarkers
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Extended Exhaled Nitric Oxide Analysis in Interstitial Lung Diseases: A Systematic Review
por: Cameli, Paolo, et al.
Publicado: (2020)

Systematic Review and Metanalysis of Oncomarkers in IPF Patients and Serial Changes of Oncomarkers in a Prospective Italian Real-Life Case Series
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Clinical phenotyping in sarcoidosis management
por: Rana, Giuseppe Domenico, et al.
Publicado: (2021)

The Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Diseases: A Real-World Study
por: Cameli, Paolo, et al.
Publicado: (2022)

Markers of Bronchiolitis Obliterans Syndrome after Lung Transplant: Between Old Knowledge and Future Perspective
por: Cavallaro, Dalila, et al.
Publicado: (2022)

Idiopathic Pulmonary Fibrosis Serum proteomic analysis before and after nintedanib therapy
por: Landi, Claudia, et al.
Publicado: (2020)

Oxygen Therapy during Exercise in Patients with Interstitial Lung Diseases
por: Viani, Magda, et al.
Publicado: (2022)

Lung cancer and interstitial lung diseases: the lack of prognostic impact of lung cancer in IPF
por: Carobene, Loredana, et al.
Publicado: (2021)

Serial KL-6 measurements in COVID-19 patients
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Hypercalciuria in Sarcoidosis: A Specific Biomarker With Clinical Utility
por: Cameli, Paolo, et al.
Publicado: (2020)

High-dose steroids for the treatment of severe COVID-19: a new therapeutic tool?
por: Cameli, Paolo, et al.
Publicado: (2021)

Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis
por: Bergantini, Laura, et al.
Publicado: (2022)

Cytological analysis of bronchoalveolar lavage fluid in asbestos-exposed workers
por: Sartorelli, Pietro, et al.
Publicado: (2020)

Neutrophil Extracellular Traps in ANCA-Associated Vasculitis and Interstitial Lung Disease: A Scoping Review
por: d’Alessandro, Miriana, et al.
Publicado: (2022)

Effect of Ambulatory Oxygen on the Respiratory Pattern during the 6 Min Walking Test in Patients with Interstitial Lung Diseases
por: Ventura, Vittoria, et al.
Publicado: (2023)

KL-6 in ANCA-Associated Vasculitis Patients with and without ILD: A Machine Learning Approach
por: Conticini, Edoardo, et al.
Publicado: (2022)

Pleuroparenchymal fibroelastosis (PPFE) associated with giant cell arteritis: A coincidence or a novel phenotype?
por: Perruzza, M., et al.
Publicado: (2019)

Metabolic Dysregulation in Idiopathic Pulmonary Fibrosis
por: Bargagli, Elena, et al.
Publicado: (2020)

Prevalence of myositis specific and associated antibodies in a cohort of patients affected by idiopathic NSIP and no hint of inflammatory myopathies
por: Conticini, Edoardo, et al.
Publicado: (2023)

Krebs von den Lungen-6 (KL-6) in cerebrospinal fluid from neurosarcoidosis patients
por: Bocci, Silvia, et al.
Publicado: (2023)

Prognostic Significance of Obstructive Sleep Apnea in a Population of Subjects with Interstitial Lung Diseases
por: Valecchi, Debora, et al.
Publicado: (2023)

Exploring the Interaction between Fractional Exhaled Nitric Oxide and Biologic Treatment in Severe Asthma: A Systematic Review
por: Pianigiani, Tommaso, et al.
Publicado: (2023)

Portable Pocket-Sized Ultrasound Scanner for the Evaluation of Lung Involvement in Coronavirus Disease 2019 Patients
por: Bennett, David, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j5444i90rrpqu5pb9es3i9ut98